Ono Pharmaceutical (OPHLF) News Today $10.18 0.00 (0.00%) As of 02/6/2025 Add Compare Share Share Headlines Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Ono Pharmaceutical (OTCMKTS:OPHLF) Issues Quarterly Earnings ResultsOno Pharmaceutical (OTCMKTS:OPHLF - Get Free Report) issued its earnings results on Monday. The company reported $0.21 earnings per share (EPS) for the quarter. Ono Pharmaceutical had a net margin of 19.64% and a return on equity of 11.85%.February 3, 2025 | marketbeat.comOno Pharmaceutical (OTCMKTS:OPHLF) Reaches New 52-Week Low - Here's WhyOno Pharmaceutical (OTCMKTS:OPHLF) Sets New 1-Year Low - Here's WhyJanuary 30, 2025 | marketbeat.comOno Pharmaceutical (OTCMKTS:OPHLF) Share Price Passes Above 50-Day Moving Average - Time to Sell?Ono Pharmaceutical (OTCMKTS:OPHLF) Stock Price Crosses Above 50 Day Moving Average - Here's What HappenedJanuary 29, 2025 | marketbeat.comOno Pharmaceutical (OTCMKTS:OPHLF) Share Price Crosses Above Fifty Day Moving Average - Here's What HappenedOno Pharmaceutical (OTCMKTS:OPHLF) Share Price Crosses Above Fifty Day Moving Average - What's Next?January 11, 2025 | marketbeat.comOno Pharmaceutical (OTCMKTS:OPHLF) Stock Price Crosses Below Two Hundred Day Moving Average - Should You Sell?Ono Pharmaceutical (OTCMKTS:OPHLF) Stock Price Passes Below 200 Day Moving Average - Should You Sell?December 14, 2024 | marketbeat.comOno Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology AreaDecember 5, 2024 | tmcnet.comOno Pharmaceutical (OTCMKTS:OPHLF) Reaches New 1-Year Low - Here's What HappenedOno Pharmaceutical (OTCMKTS:OPHLF) Hits New 12-Month Low - What's Next?December 5, 2024 | marketbeat.comNectar Classic Hybrid Mattress review 2024September 24, 2024 | fortune.comThe best Plank mattresses of 2024, tested and reviewedSeptember 24, 2024 | fortune.comTurbine Achieves Key Milestone in Collaboration with Ono PharmaceuticalSeptember 12, 2024 | tmcnet.comDelveInsight Business Research, LLP: BTK Inhibitors Market to Observe Stunning Growth by 2034 | DelveInsightSeptember 11, 2024 | finanznachrichten.deOno Pharmaceutical (OTCMKTS:OPHLF) Share Price Passes Below Two Hundred Day Moving Average of $14.99Ono Pharmaceutical (OTCMKTS:OPHLF) Share Price Passes Below Two Hundred Day Moving Average of $14.99August 31, 2024 | marketbeat.comHousing starts, Fedspeak, Harris speech: What to watchAugust 16, 2024 | uk.finance.yahoo.comOPHLF Ono Pharmaceutical Co., Ltd.August 1, 2024 | seekingalpha.comTampa pharma company stacked with former McKesson execs launches IPOJuly 25, 2024 | bizjournals.comJapan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansionApril 30, 2024 | reuters.comDeciphera Pharmaceuticals: Hold Rating Amid ONO Pharmaceutical Acquisition PremiumApril 29, 2024 | markets.businessinsider.comAbbVie Outlook: Why Humira Biosimilars Won't Undo A Projected $73 Billion In SalesApril 29, 2024 | msn.comFate Therapeutics: Looking For A Potential Turnaround In 2024April 29, 2024 | seekingalpha.comDeciphera Shares Hit 2-Year High After $2.4B Buyout Offer From ONO PharmaApril 29, 2024 | marketwatch.comUPDATE 2-Japan's Ono to buy US drugmaker Deciphera for $2.4 blnApril 29, 2024 | finance.yahoo.comDeciphera Catapults 73% On Ono Pharmaceutical's $2.4 Billion TakeoverApril 29, 2024 | finance.yahoo.comJapan's ONO Pharmaceutical to buy Deciphera for $2.4 billionApril 29, 2024 | reuters.comAI Supercharges Fentanyl Production And Distribution, Study FindsApril 27, 2024 | forbes.comOno Pharmaceutical (OTCMKTS:OPHLF) Hits New 52-Week Low at $15.96Ono Pharmaceutical (OTCMKTS:OPHLF) Hits New 12-Month Low at $15.96April 22, 2024 | marketbeat.comHookipa Pharma: 04/25/24 Update Should Be The First Of Several Positive CatalystsApril 22, 2024 | seekingalpha.comQ4 2023 Cue Biopharma Inc Earnings CallApril 9, 2024 | finance.yahoo.comOno Pharmaceutical Co Ltd (OPHLY)March 20, 2024 | uk.investing.comDon Lemon Says His Talk Show Deal with X Was Canceled After Tense Interview with Elon Musk: 'He's Mad at Me'March 14, 2024 | msn.comOno Pharmaceutical Co., - Depositary Receipt () (OPHLY) Price Target Increased by 19.99% to 7.80February 24, 2024 | msn.comOno Enters into a Research Collaboration Agreement with InveniAI to Identify Novel Therapeutic TargetsFebruary 22, 2024 | finance.yahoo.comLondon exhibition celebrates 'unknown artist' Yoko OnoFebruary 20, 2024 | msn.comOno Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion ProteinsFebruary 14, 2024 | uk.finance.yahoo.comNumab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of CancerFebruary 14, 2024 | globenewswire.comNVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?February 5, 2024 | msn.comOno Pharmaceutical Ltd (4528)February 5, 2024 | investing.comODP: A Value Play With CatalystsJanuary 16, 2024 | seekingalpha.comSnack Maker Orion Slumps After Pharma Acquisition PushJanuary 16, 2024 | wsj.comOno Enters into Research Collaboration with UK Dementia Research InstituteDecember 21, 2023 | tmcnet.comBioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer ResearchDecember 19, 2023 | markets.businessinsider.comOno Pharmaceutical Co. Ltd - ADR (OPHLY) Price Target Increased by 29.83% to 7.51December 16, 2023 | msn.comORIC Pharma NSCLC Brain Metastasis Data Is Highly InterestingDecember 9, 2023 | seekingalpha.comOno Expands Investment in Ono Venture Investment Fund I, L.P. to US$200 MillionDecember 1, 2023 | finance.yahoo.comU.S. Stocks Open Mostly Lower, With S&P 500 Falling Slightly Ahead Of Fed SpeakersNovember 28, 2023 | finance.yahoo.comNikkei Edges Lower on Yen Strength, Likely Position AdjustmentNovember 28, 2023 | finance.yahoo.comNikkei Falls 0.4% Amid JPY StrengthNovember 27, 2023 | finance.yahoo.comOzempic, Wegovy demand drives up illegal sales of weight-loss drugsNovember 1, 2023 | msn.comOno Pharmaceutical Co LtdOctober 28, 2023 | morningstar.comOno Pharmaceutical Co. (OPHLF) Upgraded to Buy: Here's WhySeptember 1, 2023 | finance.yahoo.comONO PHARMACEUTICAL is about to announce earnings — here's what Wall Street expectsJuly 30, 2023 | markets.businessinsider.com Get Ono Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for OPHLF and its competitors with MarketBeat's FREE daily newsletter. Email Address OPHLF Media Mentions By Week OPHLF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPHLF News Sentiment▼1.360.54▲Average Medical News Sentiment OPHLF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPHLF Articles This Week▼20▲OPHLF Articles Average Week Get Ono Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for OPHLF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Royalty Pharma News BeiGene News Astellas Pharma News United Therapeutics News Summit Therapeutics News Insmed News Viatris News Intra-Cellular Therapies News Genmab A/S News Genmab A/S News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:OPHLF) was last updated on 2/7/2025 by MarketBeat.com Staff From Our PartnersNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThis Crypto Is Set to Explode in JanuaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredDeepSeek Just Awoke a Sleeping GiantEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ono Pharmaceutical Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ono Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
